Facebook Pixel IT deals may be revised after new visa rules | Business Standard - newspaper - Lisez cet article sur Magzter.com

Essayer OR - Gratuit

IT deals may be revised after new visa rules

Business Standard

|

September 23, 2025

Information technology deals, that are in the process of getting signed or will be up for renewal next year, are likely to be renegotiated as the US unprecedentedly hiked the H-1B visa fees to $100,000 from next year in a huge blow to India’s flagship export industry.

- AVIK DAS

IT deals may be revised after new visa rules

Experts say that such prohibitive costs may force IT services companies to keep their prospective visa employees in India. On the other hand, they will have to step up their nearshore contingencies in Canada and Mexico and fast-track plans to hire more in the US — both will add on to their cost and impact their already-pressured margins.

Deals worth about $20 billion were up for renewal this year, Business Standard reported in March. Some of the major deals still to be closed include TCS’ deal with Star Alliance and Nielsen, Infosys’ with Daimler and GE Appliances, and Wipro’s with German energy company E.ON and Brazil’s Petrobras.

PLUS D'HISTOIRES DE Business Standard

Business Standard

Hookah served with food in restaurants to be taxed separately

Tobacco-based hookah will attract 40 % GST, while non-tobacco (herbal) hookah will be taxed at 18%

time to read

2 mins

March 04, 2026

Business Standard

RMZ aims to double its office portfolio in next five years

Bengaluru-based alternative assets owner RMZ is aiming to double its office portfolio, which currently spans 21 million square feet (msf), in the next five years through a combination of acquisitions and greenfield joint developments (JDs).

time to read

1 mins

March 04, 2026

Business Standard

Business Standard

Angels in white: Indian nurses hold the line in the shadow of conflict

“There is no official data regarding the nursing community living abroad.

time to read

1 mins

March 04, 2026

Business Standard

Delivering value, returns consistently

Fund outperforms benchmark Nifty 500 TRI and its peers

time to read

2 mins

March 04, 2026

Business Standard

'Earlier, almost any IPO could find demand. That phase is over'

After a record-breaking run last year, India’s initial public offering (IPO) market has begun 2026 on a subdued note, with volatility and geopolitical risks tempering investor appetite. But the slowdown does not signal a freeze, says Neha Agarwal, managing director (MD) and head of ECM at JM Financial. Instead, the market is entering a far more selective phase. In an interview with Samie Modak and Khushboo Tiwari in Mumbai, Agarwal outlines why the next cycle will reward quality over quantity and which sectors are best placed to attract capital. Edited excerpts:

time to read

3 mins

March 04, 2026

Business Standard

Business Standard

The vision behind Jungle Lodges & Resorts

JLR stands as a pioneering ecotourism model in India, blending conservation, community empowerment and immersive nature experiences while promoting sustainable livelihoods and environmental stewardship

time to read

3 mins

March 04, 2026

Business Standard

State simplifies ODOP, MSME approvals

The Rajasthan industries department has overhauled the approval process for the One District, One Product Policy (ODOP) and MSME Policy, with an eye on ease of doing business.

time to read

1 mins

March 04, 2026

Business Standard

Business Standard

Salary increments for 2026 likely to be 6-10%

Adecco says expectations cross 10% in high-demand areas such as AI and EVs

time to read

3 mins

March 04, 2026

Business Standard

Ensuring safety of 10 mn Indians in Gulf ‘utmost priority’: MEA

India on Tuesday said it raised its “voice clearly in favour of an early end to the conflict” in West Asia, which has evoked “great anxiety” since almost 10 million Indian citizens live and work in the Gulf region.

time to read

3 mins

March 04, 2026

Business Standard

Business Standard

Two pharmas, two playbooks

MNCs and Indian drugmakers are diverging to their mutual advantage. How much of a win-win is it?

time to read

6 mins

March 04, 2026

Listen

Translate

Share

-
+

Change font size